Suchergebnisse - "Clinical Trial, Phase III"

1

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST) : a double-blind, placebo-controlled, randomised, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Ryan, C. | Tangen, C. | Heath, E. | +16

CommentIn: Lancet. 2023 Sep 23;402(10407):1018-1019. - PMID 37524097

2

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED) : a multicentre, open-label, randomised, controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2021

von Lockman, S. | Brummel, S. | Ziemba, L. | +42

CommentIn: Lancet. 2021 Apr 3;397(10281):1240-1241. - PMID 33812476

3

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN) : a randomised, controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2020

von Sharman, J. | Egyed, M. | Jurczak, W. | +26

CommentIn: Lancet. 2020 Apr 18;395(10232):1234-1236. - PMID 32305083

4

Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Younossi, Z. | Ratziu, V. | Loomba, R. | +133

CommentIn: Lancet. 2019 Dec 14;394(10215):2131-2133. - PMID 31813639

5

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer : a randomised, phase 3, equivalence trial

enthalten in: Lancet (London, England) | 2019

von Vicini, F. | Cecchini, R. | White, J. | +24

CommentIn: Lancet. 2019 Dec 14;394(10215):2127-2129. - PMID 31813634

6

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Heijerman, H. | McKone, E. | Downey, D. | +63

CommentIn: Lancet. 2019 Nov 23;394(10212):1886-1888. - PMID 31679947

7

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Horwitz, S. | O'Connor, O. | Pro, B. | +129

CommentIn: Lancet. 2019 Jan 19;393(10168):201-202. - PMID 30663580

8

A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074) : a randomised, controlled phase 3 feasibility and efficacy study

enthalten in: Lancet (London, England) | 2018

von Miller, W. | Hoffman, I. | Hanscom, B. | +24

CommentIn: Lancet. 2018 Sep 1;392(10149):714-716. - PMID 30191815

9

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR) : an open-label, randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2018

von Parekh, D. | Reis, I. | Castle, E. | +29

CommentIn: Lancet. 2018 Jun 23;391(10139):2479-2480. - PMID 29976454

10

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS) : a randomised, open-label, phase 3 superiority trial

enthalten in: Lancet (London, England) | 2018

von Bath, P. | Woodhouse, L. | Appleton, J. | +120

CommentIn: Lancet. 2018 Mar 3;391(10123):819-821. - PMID 29274728

Filter & Sortierung